Company / Income Tax per Share
Trevi Therapeutics, Inc. Income Tax per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
-$0.00
FY2024
5-year range
-$0.00 / -$0.00
FY2020-FY2024
Trend
+9.0%
vs FY2023
Sector context
#168 of 201
Health Care
What the data says
Trevi Therapeutics, Inc.'s income tax per share of $-0.00 is lower than 84% of companies in the Health Care sector (FY2024). Income Tax per Share has increased for 6 consecutive years, from $-0.28 in FY2018 to $-0.00 in FY2024.
Based on SEC 10-K filings.
-0.00 in FY2024.
Increased from $-0.00 to $-0.00 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 201This company -$0.00 Sector average $1.35
▼
-100.0% below sector average
Key checks
Key Insights
- Trevi Therapeutics, Inc.'s income tax per share has grown for 6 consecutive years.
- In FY2024, income tax per share increased 9.0% year-over-year.
- Ranks #168 out of 201 companies in the Health Care sector.
- Lowest income tax per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.00 | +9.0% |
| FY2023 | -$0.00 | +42.1% |
| FY2022 | -$0.00 | +39.3% |
| FY2021 | -$0.00 | +7.8% |
| FY2020 | -$0.00 | +35.0% |
| FY2019 | -$0.00 | +99.5% |
| FY2018 | -$0.28 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026